Search alternatives:
web decrease » we decrease (Expand Search), mean decrease (Expand Search), teer decrease (Expand Search)
mm decrease » a decrease (Expand Search), nn decrease (Expand Search), mean decrease (Expand Search)
c decrease » c decreased (Expand Search), a decrease (Expand Search), rc decreased (Expand Search)
_ decrease » _ decreased (Expand Search)
web decrease » we decrease (Expand Search), mean decrease (Expand Search), teer decrease (Expand Search)
mm decrease » a decrease (Expand Search), nn decrease (Expand Search), mean decrease (Expand Search)
c decrease » c decreased (Expand Search), a decrease (Expand Search), rc decreased (Expand Search)
_ decrease » _ decreased (Expand Search)
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
mGluR5 receptor decreased glycinergic currents.
Published 2019“…(<b>F</b>) Postsynaptic loading of U-0126 or PD98059 prevented CHPG from decreasing glycinergic responses (U-0126, 107.6 ± 10.4% of baseline at 15–20 min post-CHPG, <i>t</i>[8] = 0.997, <i>p</i> = 0.348; PD98059, 93.1 ± 5.0% of baseline at 15–20 min post-CHPG, <i>t</i>[5] = 0.883, <i>p</i> = 0.418). …”
-
11
-
12
-
13
-
14
-
15
-
16
-
17
Predictive values of IC<sub>50</sub> in mM (FFAs) for vanadium compounds and <i>in vivo</i> observations IC<sub>50</sub> in mM (FFAs) and decreasing blood glucose level.
Published 2014“…<p>Predictive values of IC<sub>50</sub> in mM (FFAs) for vanadium compounds and <i>in vivo</i> observations IC<sub>50</sub> in mM (FFAs) and decreasing blood glucose level.…”
-
18
MCP-1-deficiency decreased CD11c-expressing cells via impairing the production of ROS and decreased activation of PLCγ2, Akt, and ERK upon M-CSF stimulation in BMM.
Published 2013“…<p>BMMs from WT (open bar) and MCP-1-KO mice (oblique-lined bar) were incubated in the presence of M-CSF (30 ng/ml) with U73122 (10 µM), Akt inhibitor IV (0.3 µM), PD098059 (5 µM), DPI (50 nM), NAC (3 mM), or H<sub>2</sub>O<sub>2</sub> (300 µM) for 4 d (A). *, <i>P</i><0.05; ***, <i>P</i><0.001 compared with vehicle-treated WT cells. …”
-
19
Skp2 inhibitor SKPin C1 decreased viability and proliferation of multiple myeloma cells and induced apoptosis
Published 2019“…In contrast, 50 μM SKPin C1 only marginally decreased viability of normal B lymphocytes in 12 h. …”
-
20